Division of Hospital Medicine, Department of Medicine, 8405MedStar Washington Hospital Center, Washington, DC, USA.
Division of Pulmonary, Critical Care, and Sleep Medicine, Care New England Medical Group, Pawtucket, RI, USA.
J Intensive Care Med. 2021 Mar;36(3):334-342. doi: 10.1177/0885066620988831.
The prognostic value of point-of-care lung ultrasound has not been evaluated in a large cohort of patients with COVID-19 admitted to general medicine ward in the United States. The aim of this study was to describe lung ultrasound findings and their prognostic value in patients with COVID-19 admitted to internal medicine ward.
This prospective observational study consecutively enrolled 105 hospitalized participants with COVID-19 at 2 tertiary care centers. Ultrasound was performed in 12 lung zones within 24 hours of admission. Findings were assessed relative to 4 outcomes: intensive care unit (ICU) need, need for intensive respiratory support, length of stay, and death.
We detected abnormalities in 92% (97/105) of participants. The common findings were confluent B-lines (92%), non-homogenous pleural lines (78%), and consolidations (54%). Large confluent B-lines, consolidations, bilateral involvement, and any abnormality in ≥ 6 areas were associated with a longer hospitalization and need for intensive respiratory support. Large confluent B-lines and bilateral involvement were also associated with ICU stay. A total lung ultrasound score <5 had a negative predictive value of 100% for the need of intensive respiratory support. A higher total lung ultrasound score was associated with ICU need (median total 18 in the ICU group vs. 11 non-ICU, p = 0.004), a hospitalization ≥ 9d (15 vs 10, p = 0.016) and need for intensive respiratory support (18 vs. 8.5, P < 0.001).
Most patients hospitalized with COVID-19 had lung ultrasound abnormalities on admission and a higher lung ultrasound score was associated with worse clinical outcomes except death. A low total lung ultrasound score (<5) had a negative predictive value of 100% for the need of intensive respiratory support. Point-of-care ultrasound can aid in the risk stratification for patients with COVID-19 admitted to general wards.
在以美国综合医学病房收治的大量 COVID-19 患者中,尚未评估即时护理肺部超声的预后价值。本研究旨在描述综合医学病房收治的 COVID-19 患者的肺部超声表现及其预后价值。
本前瞻性观察性研究连续纳入了 2 家三级保健中心的 105 名住院 COVID-19 患者。在入院后 24 小时内对 12 个肺区进行了超声检查。对 4 个结果进行了超声表现评估:入住重症监护病房(ICU)、需要强化呼吸支持、住院时间和死亡。
我们在 92%(97/105)的患者中发现了异常。常见的表现为融合 B 线(92%)、非均匀胸膜线(78%)和实变(54%)。大融合 B 线、双侧受累以及≥6 个区域的任何异常与住院时间延长和需要强化呼吸支持相关。大融合 B 线和双侧受累也与入住 ICU 相关。总肺部超声评分<5 对需要强化呼吸支持具有 100%的阴性预测值。总肺部超声评分较高与入住 ICU 相关(ICU 组中位数为 18 分,非 ICU 组为 11 分,p=0.004)、住院时间≥9d(15 分与 10 分,p=0.016)和需要强化呼吸支持(18 分与 8.5 分,P<0.001)相关。
大多数因 COVID-19 住院的患者在入院时存在肺部超声异常,较高的肺部超声评分与临床结局恶化相关,除死亡外。总肺部超声评分低(<5)对需要强化呼吸支持的阴性预测值为 100%。即时护理超声可帮助对收入普通病房的 COVID-19 患者进行风险分层。